In MSI CRC, another CD4+ T cell subset Th1 and cytotoxic CD8+ T cells are enriched (Le Gouvello et al, 2008; Lee et al, 2020; Mlecnik et al, 2016; Pelka et al, 2021; Zhang et al, 2018). The gene discussed is CD4; the disease is colorectal carcinoma.